HROW · Harrow Inc
United States · RS rating 23 · As of 2026-11-03
| Price | 28.54 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 42 / 23 / 34 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 11 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -535.3% |
| Sales growth Q/Q | +24.4% |
| Distance from 52-week high | +47.9% |
| Market cap (USD) | $1.4B |